5/3/2011

Watson Laboratories began selling methylphenidate hydrochloride, an extended-release drug for
attention-deficit/hyperactivity disorder in patients ages 6 to 65. It is a generic version of Ortho-McNeil-Janssen Pharmaceuticals' Concerta.

Full Story:
Drug Store News

Related Summaries